4 Agencies Chase Incontinence Drug

Four global shops are vying to handle ad duties outside the U.S. for a new urinary-incontinence drug from Eli Lilly & Co. and Boehringer Ingelheim, sources said. The finalists for the estimated $25 million account are WPP’s J. Walter Thompson, London; Omnicom’s BBDO, Dusseldorf, Germany; Interpublic’s Foote, Cone & Belding, New York; and Havas’ Euro RSCG Life, London, sources said. Final pitches are scheduled for mid-October at Boehringer Ingelheim’s headquarters in Ingelheim, Germany, said sources. The agencies either declined comment or could not be reached.